Apoorva Mandavilli, a science and global health reporter for The New York Times, dives into the alarming spread of the H5N1 bird flu virus and its potential impact on public health. She discusses how the virus has evolved, increasing risks to both animal and human populations. The conversation highlights the U.S. government's preparedness deficiencies and communication failures amid rising concerns of another pandemic. With egg prices skyrocketing and public trust eroding, Mandavilli emphasizes the urgent need for effective responses to future health crises.

Apoorva Mandavilli, a science and global health reporter for The New York Times, delves into the implications of the Biden administration's decision to end the COVID-19 public health emergency. This transition signals a new phase in pandemic response, complicating access to tests and treatments, particularly for those uninsured. The conversation also touches on the political ramifications of ceasing Title 42 and addresses the evolving perspectives on living with COVID-19, emphasizing the importance of personal risk assessments as society adapts to a new normal.

Apoorva Mandavilli, a science and global health reporter for The New York Times, delves into the recent shift to annual COVID vaccinations. She discusses the end of booster shots and the strategic changes as infections rise again. Mandavilli explains who should get the new vaccine and when, while emphasizing the importance of vaccination against long-term effects. The conversation also touches on adapting to evolving public health guidelines, personal responsibility, and the broader implications of these changes amid ongoing global events.

Apoorva Mandavilli, a science and global health reporter for The New York Times, dives into the looming ‘tripledemic’ of RSV, flu, and COVID-19. She explores why children are facing the brunt of these viral infections, sharing a heartfelt story of a mother whose infant struggled with severe RSV. The discussion also highlights limited treatments, the importance of vaccinations, and the challenges posed by new COVID variants as winter approaches. Mandavilli emphasizes the critical need for public health awareness and vigilance.

Apoorva Mandavilli, a seasoned science and global health reporter for The New York Times, dives into the faltering negotiations for a global pandemic preparedness treaty. She discusses the stark vaccine inequities revealed during COVID, highlighting the struggles of lower-income nations. Mandavilli sheds light on the complex power dynamics with pharmaceutical companies and emphasizes the urgent need for equitable health solutions. Her frontline reporting showcases the critical role of journalists in conveying this crucial information during crises.

Apoorva Mandavilli, a science and health journalist for The New York Times, discusses the H5N1 bird flu outbreak, dubbed an 'existential threat' to biodiversity. She outlines how the virus is impacting wildlife and the potential risks to human health. Mandavilli highlights the role of environmental degradation and industrial agriculture in exacerbating this crisis. Furthermore, she critiques U.S. pandemic response measures and underscores the urgent need for improved monitoring and vaccination strategies to combat this adaptable virus.

Gabriela Glueck, the Julia Child fellow, dives into the world of lab-grown chocolate, revealing its sustainable production methods. Apoorva Mandavilli discusses the rising threat of bird flu and its impact on food supply and egg prices. Genevieve Ko shares innovative egg substitutes like aquafaba and flax gel for cooking. Steve Sando, of Rancho Gordo, showcases the versatility of heirloom beans while sharing culinary tips. From chocolate alternatives to bean cooking secrets, this chat mixes science with culinary creativity!

Apoorva Mandavilli, a science and global health reporter for The New York Times, dives into the alarming spread of monkeypox in the U.S. Initially deemed manageable, the virus quickly escalated into a public health crisis. Apoorva discusses challenges in testing and vaccination, particularly affecting the LGBTQ+ community. She shares personal accounts of individuals facing difficulties in securing treatment. The conversation sheds light on systemic weaknesses in the public health infrastructure and the urgent need for improved responses to outbreaks.

Apoorva Mandavilli, a science and global health reporter for The New York Times, dives into the staggering statistic that around 60% of Americans have been infected with COVID-19. She discusses the elusive nature of herd immunity and the ongoing risks faced by the population, especially children. The conversation also touches on the complexity of vaccination strategies, personal risk assessments, and the ethical challenges surrounding post-exposure testing. Mandavilli emphasizes the shift in public health goals towards preventing severe illness rather than simply counting infections.

Apoorva Mandavilli, a science and global health reporter for The New York Times, dives into the alarming rise of the BA.2 variant and its implications. She discusses the surge in COVID cases in China and Europe, set against the U.S. easing restrictions. The conversation highlights the concerning potential for a new wave in America, the uneven impact on vulnerable populations, and the ongoing debate around booster shots and vaccine effectiveness. Mandavilli sheds light on the stark divide between pandemic fatigue in the U.S. and the reality of rising cases abroad.